Earnings
CLVS
4.760
+7.21%
0.320
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
161.83M
134.83M
--
20.56M
--
--
14.10M
--
26.52M
--
8.46M
177.00K
366.47M
43.43M
--
--
--
63.07M
62.92M
--
133.71M
303.14M
669.60M
--
32.24M
0.00
--
--
--
--
--
97.34M
--
--
--
3.50M
133.08M
679.74M
--
--
--
31.04M
710.78M
843.86M
55.00K
2.11B
-2.24B
--
--
--
-174.26M
-174.26M
669.60M
FY 2018-12-31
221.88M
298.27M
--
12.89M
--
--
2.27M
--
27.07M
--
7.34M
2.58M
572.30M
26.52M
--
--
--
63.07M
51.93M
--
149.73M
291.26M
863.56M
--
28.52M
0.00
--
--
--
--
--
95.35M
--
--
--
847.00K
125.75M
575.47M
--
--
--
15.87M
591.34M
717.09M
53.00K
2.03B
-1.84B
--
--
--
146.47M
146.47M
863.56M
FY 2017-12-31
464.20M
99.53M
--
6.18M
--
--
2.03M
--
27.51M
--
6.84M
20.65M
626.94M
4.01M
--
--
--
65.22M
19.56M
--
19.50M
108.29M
735.23M
--
15.15M
0.00
--
--
--
--
--
44.35M
--
--
--
22.02M
81.52M
282.41M
--
--
--
3.67M
286.08M
367.59M
51.00K
1.89B
-1.48B
--
--
--
367.64M
367.64M
735.23M
FY 2016-12-31
216.19M
50.00M
--
121.00K
--
--
3.25M
--
--
--
9.77M
90.00K
279.41M
4.44M
--
--
--
57.19M
21.05M
--
2.47M
85.15M
364.56M
--
10.91M
0.00
--
--
--
--
--
54.69M
--
--
--
20.06M
85.66M
281.13M
--
--
0.00
1.41M
282.53M
368.19M
39.00K
1.17B
-1.13B
--
--
--
-3.63M
-3.63M
364.56M
FY 2015-12-31
278.76M
249.83M
--
5.28M
--
--
5.28M
--
--
--
5.63M
199.00K
539.70M
4.95M
--
--
--
59.33M
101.50M
--
7.91M
173.69M
713.39M
--
11.26M
0.00
--
--
--
--
--
64.32M
--
--
--
--
75.58M
279.88M
--
--
31.13M
26.14M
337.16M
412.74M
38.00K
1.13B
-781.91M
--
--
--
300.65M
300.65M
713.39M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CLVS latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Clovis Oncology recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.